Blog Header

By: Sean Preci

24 Jul, 2018A.I. – Elevating the Computing Power of Scientists and Companies


AI’s use in drug discovery is beginning to gain momentum, as seen by the number of large pharmas are already working with smaller AI-based biotechs. Though the term “AI” can carry certain mixed perceptions, scientists within pharma and biotech are starting to realize that AI is poised to make the human element more effective.

Read More

23 Apr, 2018The Threat of a Black Market Within the Market: The Hidden Risks of Sourcing Human Biological Samples


The direct and indirect impact of sourcing human biological samples present serious risks for the scientific research community. Through Compli™ -a governance process that provides standardization, transparency and ensures ethical sourcing through one single service- researchers can now mitigate risk and reduce overhead while implementing a formal compliance process.

Read More

05 Mar, 2018Tech Snapshot™: Tracking the Digital Transformation in the Life Sciences


A few readers of this blog series might recall the thrill of operating the so-called Genetics Computing Group “Wisconsin Package” running on the OpenVMS operating system. Subsequently, its GUI SeqWeb became a precursor to today’s cloud computing concept.

Read More

05 Feb, 2018Tech Snapshot™: Exploring the Role of Data Sciences in the Life Sciences, Omics Analytics and Health IT


In the first of a series of posts, Tech Snapshot will explore subsets of Data Sciences—life sciences data services, omics analytics and health IT—followed by an overview of three different organizations to assist scientists in furthering their research in this burgeoning area.

Read More

06 Jan, 2018The Mad Scramble to Fix Microprocessor Security Flaws


At Scientist.com we take cybersecurity, data privacy, client confidentiality and PII very seriously. With a decade of experience building and operating white label and public marketplaces, Scientist.com knows the importance of protecting our clients’ information.

Read More